Divya A. Patel

发表

Development and Evaluation of a PCR and Mass Spectroscopy- based (PCR-MS) Method for Quantitative, Type-specific Detection of Human Papillomavirus

M. Ruffin, D. Newton, P. Oeth, 2010 .

Inhibitor of differentiation 4 (ID4): From development to cancer.

Derrick J. Morton, J. Carey, J. Chaudhary, 2015, Biochimica et biophysica acta.

Interferon inducible antiviral MxA is inversely associated with prostate cancer and regulates cell cycle, invasion and Docetaxel induced apoptosis

A. Hunt, A. Knowell, J. Chaudhary, 2015, The Prostate.

Epigenetic inactivation of inhibitor of differentiation 4 (Id4) correlates with prostate cancer

J. Carey, Swathi Chinaranagari, J. Chaudhary, 2012, Cancer medicine.

Basic helix loop helix ( bHLH ) transcription factor 3 ( TCF 3 , E 2 A ) is regulated by androgens in prostate cancer cells

Swathi Chinaranagari, J. Chaudhary, Divya A. Patel, 2015 .

Inactivation of ID4 promotes a CRPC phenotype with constitutive AR activation through FKBP52

Derrick J. Morton, Peri Nagappan, J. Sivils, 2017, Molecular oncology.

ID4 promotes AR expression and blocks tumorigenicity of PC3 prostate cancer cells.

Derrick J. Morton, S. Upadhyay, J. Chaudhary, 2016, Biochemical and biophysical research communications.

Simultaneous quantification of teneligliptin hydrobromide and metformin hydrochloride: An improved HPTLC method with implementation of Plackett-Burman design

Mehul M. Patel, U. Shah, Divya A. Patel, 2021 .

Intra-tumoral delivery of functional ID4 protein via PCL/maltodextrin nano-particle inhibits prostate cancer growth

Derrick J. Morton, J. Chaudhary, Pankaj Sharma, 2016, Oncotarget.

Inhibitor of differentiation 4 (ID4) inactivation promotes de novo steroidogenesis and castration-resistant prostate cancer.

N. Bowen, Peri Nagappan, A. Knowell, 2014, Molecular endocrinology.

Id4 deficiency attenuates prostate development and promotes PIN-like lesions by regulating androgen receptor activity and expression of NKX3.1 and PTEN

Peri Nagappan, A. Knowell, Swathi Chinaranagari, 2013, Molecular Cancer.

Increased expression of bHLH transcription factor E2A (TCF3) in prostate cancer promotes proliferation and confers resistance to doxorubicin induced apoptosis.

J. Chaudhary, Divya A. Patel, 2012, Biochemical and biophysical research communications.

ID4 regulates transcriptional activity of wild type and mutant p53 via K373 acetylation

Derrick J. Morton, A. Knowell, J. Chaudhary, 2016, Oncotarget.

Id4 dependent acetylation restores mutant-p53 transcriptional activity

Derrick J. Morton, A. Knowell, J. Chaudhary, 2013, Molecular Cancer.

Id1 and Id3 expression is associated with increasing grade of prostate cancer: Id3 preferentially regulates CDKN1B

J. Chaudhary, Pankaj Sharma, Divya Patel, 2012, Cancer medicine.

Basic helix loop helix (bHLH) transcription factor 3 (TCF3, E2A) is regulated by androgens in prostate cancer cells.

Swathi Chinaranagari, J. Chaudhary, Divya A. Patel, 2015, American journal of cancer research.